BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
G-protein-coupled receptor binding
,
Ischemia
,
Stem cell
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
transcript factor ii
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
HNF1β-associated cyst development and electrolyte disturbances are not explained by BAIAP2L2 express…
Slug enables redox-sensitive trans-activation of LRP1 by COUP-TFII: Implication in antifibrotic inte…
Mechanisms of ion transport regulation by HNF1β in the kidney: beyond transcriptional regulation of …
Orphan nuclear receptor COUP-TFII enhances myofibroblast glycolysis leading to kidney fibrosis.
The role of Toxoplasma TFIIS-like protein in the early stages of mRNA transcription.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to M…
Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Sarcopenia and Related Factors in Lipedema
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glio…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ